Drug name - Detectnet

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10159759 RADIOMEDIX Pet tracer for imaging of neuroendocrine tumors Aug, 2032

(9 years from now)

US10383961 RADIOMEDIX PET tracer for imaging of neuroendocrine tumors Aug, 2032

(9 years from now)

US11160888 RADIOMEDIX PET tracer for imaging of neuroendocrine tumors Aug, 2032

(9 years from now)

Drugs and Companies using COPPER DOTATATE CU-64 ingredient

Treatment: Use of cu-64 dotatate with positron emission tomography (pet) for localization of somatostatin receptor positive neuroendocrine tumors (nets) in adult patients

Dosage: SOLUTION;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
4mL (1mCi/ML) SOLUTION;INTRAVENOUS Prescription

availability in other generic markets.

Click on the highlighted region to filter.